Skip to main content

Peer Review reports

From: Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease

Original Submission
7 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 May 2021 Reviewed Reviewer Report
3 Jun 2021 Author responded Author comments - Yanfeng Xiao
Resubmission - Version 3
3 Jun 2021 Submitted Manuscript version 3
11 Sep 2021 Reviewed Reviewer Report
11 Oct 2021 Reviewed Reviewer Report
30 Nov 2021 Author responded Author comments - Yanfeng Xiao
Resubmission - Version 4
30 Nov 2021 Submitted Manuscript version 4
2 Dec 2021 Author responded Author comments - Yanfeng Xiao
Resubmission - Version 5
2 Dec 2021 Submitted Manuscript version 5
23 Dec 2021 Reviewed Reviewer Report
18 Jan 2022 Reviewed Reviewer Report - Toshifumi Yodoshi
29 Jan 2022 Author responded Author comments - Yanfeng Xiao
Resubmission - Version 6
29 Jan 2022 Submitted Manuscript version 6
Publishing
21 Feb 2022 Editorially accepted
26 Feb 2022 Article published 10.1186/s12902-022-00967-y

You can find further information about peer review here.

Back to article page